Post-Market Surveillance

Post-Market Surveillance under the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 requires manufacturers to continuously collect, assess and analyse data on the performance and safety of their devices after they are placed on the market. The process aims to identify emerging risks, verify compliance with the intended use, and trigger corrective actions or updates to the technical documentation throughout the product's lifecycle.